Enfusion

Enfusion Cash Conversion Cycle

Delisted

The Cash Conversion Cycle (CCC) of Enfusion (ENFN) as of Nov 7, 2026 is 53.03. In the previous year, Cash Conversion Cycle (CCC) was 44.69 — a change of 18.66% (higher).

Cash Conversion Cycle

53.03

YoY

18.66%

Last updated:

Cash Conversion Cycle (CCC) of Enfusion is 2024 53.03 . Cash Conversion Cycle (CCC) of Enfusion was 2023 44.69 . It decreases by 18.66% higher compared to the previous year.

The Enfusion Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2019
46.12 USD
Jan 1, 2020
47.70 USD
Jan 1, 2021
30.50 USD
Jan 1, 2022
97.13 USD
Jan 1, 2023
44.69 USD
Jan 1, 2024
53.03 USD
The Enfusion Cash Conversion Cycle history
YEARCash Conversion CycleYoY
53.03+18.66%
44.69-53.99%
97.13+218.49%
30.50-36.06%
47.70+3.42%
46.12—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enfusion Stock analysis

What does Enfusion do? Enfusion Inc. generates revenue through cloud-native multi-tenant software solutions tailored for alternative and institutional investment managers. Its core products include the Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System, and Enfusion Analytics System, which collectively enable real-time investment decision-making. The company serves investment managers who require integrated systems for the full investment lifecycle, with PMS constructing and rebalancing portfolios while generating a real-time investment book of record, and OEMS facilitating electronic trade order communication for portfolio managers, traders, compliance teams, and analysts. The company's solution integrates technology-powered managed services to drive insights and control over investment operations. Enfusion's end-to-end functionality supports the entire investment process, from portfolio construction to trade execution, with PMS and OEMS operating in tandem to provide a seamless workflow. Investment managers across alternative and institutional segments purchase these integrated systems to enhance operational efficiency and decision-making capabilities. Enfusion's software is designed to serve the full investment lifecycle, with its systems integrated to provide a unified platform for portfolio management, order execution, accounting, and analytics. The company's revenue model is based on delivering these comprehensive solutions to investment managers who rely on real-time data and integrated workflows to manage their operations effectively. Enfusion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enfusion stock

Cash Conversion Cycle (CCC) of Enfusion is 53.03 in 2024.

Cash Conversion Cycle (CCC) of Enfusion changed from 44.69 to 53.03, representing a 18.66% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) Enfusion since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s Enfusion with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Enfusion

All Key Metrics — Enfusion